Edition:
India

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,106.00GBp
23 Aug 2019
Change (% chg)

-13.00 (-0.21%)
Prev Close
6,119.00
Open
6,157.00
Day's High
6,163.00
Day's Low
6,095.00
Volume
773,284
Avg. Vol
1,301,290
52-wk High
7,174.00
52-wk Low
5,559.00

Select another date:

Tue, Jul 30 2019

Photo

Reckitt cuts sales target as China infant formula demand slows

LONDON Reckitt Benckiser cut its full-year revenue target after reporting lower than expected sales in its last quarter under long-time chief executive Rakesh Kapoor, hurt by a surprise slowdown in demand for infant formula in China.

UPDATE 4-Reckitt cuts sales target as China infant formula demand slows

* Health unit posts surprise sales drop due to China slowdown

BP surge lifts FTSE 100 to 11-mth high; Centrica slumps

July 30 A surge in oil major BP offset steep losses in consumer goods giant Reckitt Benckiser and energy utility Centrica and lifted London's FTSE 100 to a fresh 11-month high on Tuesday.

Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment. | Video

Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment. | Video

Indivior says Reckitt settlement in U.S. unrelated to its cases

Drugmaker Indivior Plc said on Thursday its former parent Reckitt Benckiser's $1.4 billion settlement with authorities in the United States was separate to its ongoing legal proceedings.

UPDATE 6-Reckitt to pay $1.4 bln to end U.S. opioid addiction treatment probes

* RB shares rise as much as 3.3% (Recasts with details from Justice Department settlement announcement)

Indivior says Reckitt settlement in U.S. unrelated to its cases

July 11 Drugmaker Indivior Plc said on Thursday its former parent Reckitt Benckiser's $1.4 billion settlement with authorities in the United States was separate to its ongoing legal proceedings.

FTSE 100 rebounds from 4-day losing streak on Fed rate cut hopes, Reckitt settlement

July 11 London's main index snapped a four-day losing streak on Thursday as comments from the U.S. central bank reinforced bets of an interest rate cut and lifted broader sentiment, while Reckitt gained after agreeing to a settlement with U.S. authorities.

UK's Reckitt to pay up to $1.4 bln to resolve Indivior probe

July 11 Britain's Reckitt Benckiser said it would pay up to $1.4 billion to resolve all U.S. federal investigations into the firm in connection with the sales and marketing of Suboxone Film by its former prescription pharmaceuticals business Indivior. (Reporting by Noor Zainab Hussain in Bengaluru Editing by Edmund Blair)

Select another date: